Safety: Its important to note that while AOD-9604 demonstrated excellent safety and tolerability, the clinical development program was ultimately discontinued because efficacy for weight loss did not meet regulatory approval standards
A pharmacy must evaluate the law and FDA policy in effect at the time of compounding, including the exact substance, formal list status, any applicable interim policy, state requirements, sourcing, formulation, and patient-specific prescription rules
Support for Other Healthy Habits By curbing appetite and fostering a healthier relationship with food, Semaglutide (Wegovy) makes it easier to adopt and stick to other weight-loss strategies, like regular exercise and portion control
Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2019
doi: 10.1016/j.bbrc.2015.01.098 184 SpielmanLJGibsonDLKlegerisA
Cell Biochem Funct 2002